Chéradame S - Search Results

1

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity.

Etienne MC, Ilc K, Formento JL, Laurent-Puig P, Formento P, Cheradame S, Fischel JL, Milano G. Etienne MC, et al. Among authors: cheradame s. Br J Cancer. 2004 Jan 26;90(2):526-34. doi: 10.1038/sj.bjc.6601523. Br J Cancer. 2004. PMID: 14735204 Free PMC article.

2

Variable intrinsic sensitivity of human tumor cell lines to raltitrexed (Tomudex) and folylpolyglutamate synthetase activity.

Chéradame S, Chazal M, Fischel JL, Formento P, Renée N, Milano G. Chéradame S, et al. Anticancer Drugs. 1999 Jun;10(5):505-10. doi: 10.1097/00001813-199906000-00010. Anticancer Drugs. 1999. PMID: 10477170

3

Synthesis and Characterization of Nitrido Tc(V) and Re(V) Complexes with Ferrocenedithiocarboxylate {FcCS(2) = [Fe(C(5)H(4)CS(2))(C(5)H(5))](-)}.

Bolzati C, Uccelli L, Duatti A, Venturini M, Morin C, Chéradame S, Refosco F, Ossola F, Tisato F. Bolzati C, et al. Among authors: cheradame s. Inorg Chem. 1997 Aug 13;36(17):3582-3585. doi: 10.1021/ic961408t. Inorg Chem. 1997. PMID: 11670047

4

Tumoral-reduced folates and clinical resistance to fluorouracil-based treatment in head and neck cancer patients.

Chéradame S, Etienne MC, Formento P, Schneider M, Dassonville O, Demard F, Milano G. Chéradame S, et al. J Clin Oncol. 1997 Jul;15(7):2604-10. doi: 10.1200/JCO.1997.15.7.2604. J Clin Oncol. 1997. PMID: 9215831

5

Relevance of tumoral folylpolyglutamate synthetase and reduced folates for optimal 5-fluorouracil efficacy: experimental data.

Chéradame S, Etienne MC, Chazal M, Guillot T, Fischel JL, Formento P, Milano G. Chéradame S, et al. Eur J Cancer. 1997 May;33(6):950-9. doi: 10.1016/s0959-8049(97)00028-2. Eur J Cancer. 1997. PMID: 9291820

6

Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data.

Chazal M, Cheradame S, Formento JL, Francoual M, Formento P, Etienne MC, François E, Richelme H, Mousseau M, Letoublon C, Pezet D, Cure H, Seitz JF, Milano G. Chazal M, et al. Among authors: cheradame s. Clin Cancer Res. 1997 Apr;3(4):553-7. Clin Cancer Res. 1997. PMID: 9815719

7

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

Etienne MC, Chéradame S, Fischel JL, Formento P, Dassonville O, Renée N, Schneider M, Thyss A, Demard F, Milano G. Etienne MC, et al. Among authors: cheradame s. J Clin Oncol. 1995 Jul;13(7):1663-70. doi: 10.1200/JCO.1995.13.7.1663. J Clin Oncol. 1995. PMID: 7602356

8

Wide range for optimal concentration of folinic acid in fluorouracil modulation--experimental data on human tumour cell lines.

Beck A, Etienne MC, Chéradame S, Fischel JL, Formento P, Guillot T, Milano G. Beck A, et al. Among authors: cheradame s. Eur J Cancer. 1994;30A(10):1522-6. doi: 10.1016/0959-8049(94)e0063-a. Eur J Cancer. 1994. PMID: 7833112

9

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.

Beck A, Etienne MC, Chéradame S, Fischel JL, Formento P, Renée N, Milano G. Beck A, et al. Among authors: cheradame s. Eur J Cancer. 1994;30A(10):1517-22. doi: 10.1016/0959-8049(94)00216-r. Eur J Cancer. 1994. PMID: 7833111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters